Estetra

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)

Role: lead

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

Role: lead

International Active Surveillance Study: Safety of Estrogen Estetrol (E4) Contraceptive Study (INAS-SEECS)

Role: collaborator

International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study

Role: collaborator

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I)

Role: lead

Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female Adolescents

Role: lead

Effect of Estetrol Monohydrate (E4) on QTc Interval

Role: lead

E4/DRSP Ovarian Function Inhibition Study

Role: lead

E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study

Role: lead

E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study

Role: lead

Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol

Role: lead

Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study

Role: lead

"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"

Role: lead

Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers

Role: lead

E4/DRSP Single and Multiple Dose PK and Early QT Study

Role: lead

Effect of Food on the Bioavailability of 15 mg Estetrol/3 mg Drospirenone Tablets in Healthy Female Volunteers

Role: lead

Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2

Role: lead